Loading...

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab

Introduction We present a case of a patient with osteoporosis and chronic kidney disease (CKD)-induced secondary hyperparathyroidism who developed severe hypophosphatemia and increasing parathyroid hormone (PTH) level after receiving Denosumab. Clinical Case 90-year-old male with CKD stage 3 present...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Endocr Soc
Main Authors: Adepoju, Yewande, Khitan, Zeid, Khthir, Rodhan
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553052/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-514
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!